Pacific Biosciences of California PACB Operating lease liabilities
Operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's operating lease liabilities?
- Pacific Biosciences of California (PACB) reported operating lease liabilities of $1.43M in Q1 2026.
- How has Pacific Biosciences of California's operating lease liabilities changed year-over-year?
- Pacific Biosciences of California's operating lease liabilities increased by 188.1% year-over-year, from -$1.62M to $1.43M.
- What is the long-term trend for Pacific Biosciences of California's operating lease liabilities?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's operating lease liabilities has grown at a -54.6% compound annual growth rate (CAGR), from -$7.72M to $723K.